Inverse Relationship Between Obesity and Serum Prostate-Specific Antigen Level in Healthy Japanese Men: A Hospital-Based Cross-Sectional Survey, 2004-2006

Urology

Volumn 72, Issue 3, 2008, Pages 561-565

  Ando, Ryosuke ^a,b   Nagaya, Teruo ^a   Hashimoto, Yoshihiro ^a   Suzuki, Sadao ^a   Itoh, Yasunori ^a   Umemoto, Yukihiro ^a   Ikeda, Nobuo ^b   Tozawa, Keiichi ^a   Kohri, Kenjiro ^a   Tokudome, Shinkan ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Chunichi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; AFRICAN AMERICANS; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HOSPITALS; HUMANS; JAPAN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROSTATE-SPECIFIC ANTIGEN;

EID: 50249083876     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.04.008     Document Type: Article

References (30)

1. Sirovich B.E., Schwartz L.M., and Woloshin S. Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence?. JAMA 289 (2003) 1414-1420
2. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 270 (1993) 860-864
3. Ochiai A., Fritsche H.A., and Babaian R.J. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Urology 66 (2005) 819-823
4. Kristal A.R., Chi C., Tangen C.M., et al. Association of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 106 (2006) 320-328
5. Werny D.M., Thompson T., Saraiya M., et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16 (2007) 70-76
6. Baillargeon J., Pollock B.H., Kristal A.R., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092-1095
7. Barqawi A.B., Golden B.K., O'Donnell C., et al. Observed effect of age and body mass index on total and complexed PSA: Analysis from a national screening program. Urology 65 (2005) 708-712
8. Banez L.L., Hamilton R.J., Partin A.W., et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 298 (2007) 2275-2280
9. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. WHO Tech Rep Ser 894 (2000) 1-253
10. The National Nutrition Survey in Japan developed by the Ministry of Health, Labor and Welfare in 2003. Available from: http://www.mhlw.go.jp. Accessed September 9, 2007.
11. Parkin D.M., Whelan S.L., Ferlay J., et al. Cancer Incidence in Five Continents. Vol VIII (2002), IARC Scientific Publications, Lyon 633-635
12. Ajiki W., Tsukuma H., Oshima A., et al. Cancer incidence and incidence rates in Japan in 1999: Estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34 (2004) 352-356
13. Ku J.H., Kim M.E., Lee N.K., et al. Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 61 (2003) 132-136
14. Roubenoff R., Dallal G.E., and Wilson P.W. Predicting body fatness: The body mass index vs estimation by bioelectrical impedance. Am J Pub Health 85 (1995) 726-728
15. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
16. Hoffman R.M. Viewpoint: Limiting prostate cancer screening. Ann Intern Med 144 (2006) 438-440
17. Andersson S.O., Wolk A., Bergstrom R., et al. Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 89 (1997) 385-389
18. Mydlo J.H., Tieng N.L., Volpe M.A., et al. A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate. Prostate Cancer Prostatic Dis 4 (2001) 101-105
19. Freedland S.J., Aronson W.J., Kane C.J., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22 (2004) 446-453
20. Strom S.S., Wang X., Pettaway C.A., et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 11 (2005) 6889-6894
21. Scales C.D., Curtis L.H., Norris R.D., et al. Relationship between body mass index and prostate cancer screening in the United States. J Urol 177 (2007) 493-498
22. Gapstur S.M., Gann P.H., Kopp P., et al., CARDIA male hormone study. Serum androgen concentrations in young men: A longitudinal analysis of associations with age, obesity, and race. Cancer Epidemiol Biomarkers Prev 11 (2002) 1041-1047
23. Farnsworth W.E. Estrogen in the etiopathogenesis of BPH. Prostate 41 (1999) 263-274
24. Young C.Y., Montgomery B.T., Andrews P.E., et al. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51 (1991) 3748-3752
25. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1994-2004. JAMA 295 (2006) 1549-1555
26. Benson M.C., and Olsson C.A. Prostate specific antigen and prostate specific antigen density: Role in patient evaluation and management. Cancer 74 (1994) 1667-1673
27. Catalona W.J., Smith D.S., Wolfert R.L., et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274 (1995) 1214-1220
28. Nam R.K., Toi A., Klotz L.H., et al. Assessing individual risk for prostate cancer. J Clin Oncol 25 (2007) 3582-3588
29. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 350 (2004) 2239-2246
30. Andreoli A., Melchiorri G., De Lorenzo A., et al. Bioelectrical impedance measures in different position and vs dual-energy X-ray absorptiometry (DXA). J Sports Med Phys Fit 42 (2002) 186-189